Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
March 25, 2024 06:15 ET
|
Sagimet Biosciences Inc.
Reported positive topline data from the Phase 2b FASCINATE-2 trial; at week 52 denifanstat met both primary efficacy endpoints and demonstrated statistically significant reduction in fibrosis ...
Issue of Equity and Total Voting Rights and Capital
March 25, 2024 06:15 ET
|
Albion Development VCT PLC - Ordinary Shares
ALBION DEVELOPMENT VCT PLC Issue of Equity and Total Voting Rights LEI Code 213800FDDMBD9QLHLB38 The first allotment for the 2023/2024 tax year of new ordinary shares of nominal value 1 penny per...
Man Group PLC : Form 8.3 - Barratt Developments plc
March 25, 2024 06:13 ET
|
Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Dimensional Fund Advisors Ltd. : Form 8.3 - Irish Residential Properties REIT PLC
March 25, 2024 06:12 ET
|
Dimensional Fund Advisors Ltd
FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT...
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
March 25, 2024 06:09 ET
|
Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Dimensional Fund Advisors Ltd. : Form 8.3 - Redrow plc - Ordinary Shares
March 25, 2024 06:09 ET
|
Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
Man Group PLC : Form 8.3 - Smith (DS) plc
March 25, 2024 06:07 ET
|
Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Technip Energies and LanzaTech Selected by the US Department of Energy to Receive $200M Investment for Breakthrough, Replicable Decarbonized Ethylene Commercial Facility
March 25, 2024 06:06 ET
|
LanzaTech Inc.
Today, Technip Energies and LanzaTech Global, Inc. (NASDAQ: LNZA) were selected by the U.S. Department of Energy (DOE) Office of Clean Energy D
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
March 25, 2024 06:05 ET
|
Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
March 25, 2024 06:05 ET
|
ProKidney
Dr. Ulrich Ernst joins as Executive Vice President of Technical Operations with a deep background and expertise in process development and manufacturing of cell therapies Mr. Lucio Tozzi joined in...